Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Xaliproden for oxaliplatin-induced neurotoxicity in metastatic colorectal cancer
NCT00305188Phase 3Completed
- Sponsor
- Sanofi
- Start
- Dec 2005
- Primary completion
- Oct 2009
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of xaliproden in peripheral sensory neuropathy, sponsored by Sanofi. Started Dec 2005; status: completed.
02
Drugs
xaliproden
03
Conditions
peripheral sensory neuropathy
Beyond the preview
Go deeper on NCT00305188.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00305188.